Related Experiment Video
Updated: May 6, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Postmarketing adverse drug reactions: A duty to report?
1Department of Neurology (EK, DB), Oregon Health & Science University; Neurology Service (EK, DB), Department of Veterans Affairs Medical Center; and MS Center of Excellence-West (DB), Department of Veterans Affairs Medical Center, Portland, OR.
Abstract:
Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Pharmaceutical Poisoning: Potential Scenarios
FDA Approved Drugs: Changes to Approved Drugs
Drug Toxicity: Risk factors
Drug Toxicity: Overview

